UPM Pharmaceuticals
Independent CDMO specializing in oral solids, semi-solids, and controlled substances with 475,000 sq ft Bristol, TN facility.
Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized. Headquartered in Bristol, United States.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Manufacturing (M)
Synthetic chemistry infrastructure
- Max chemical scale
- Commercial (>100 kg / tonne)
- Capabilities
- HPAPIDEA licensed
Fill-finish formats
Regulatory clearances
Services
- Formulation Development
- CMC Analytical Development
- Stability Testing & Storage
- Quality Control Testing
- Process Development
- Technology Transfer
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace
- Controlled Substance Manufacturing
- HPAPI Manufacturing (High-Potency)
About this organization
Overview
UPM Pharmaceuticals is an independent, family-owned contract development and manufacturing organization (CDMO) with more than 25 years of operational history. The company combines enterprise-level capabilities with the flexibility and transparency of a family-owned business, serving pharmaceutical companies of all sizes from early-stage biotech to established Big Pharma.
Core Services
Drug Formulation & Development
- Drug formulation development and analytical method development
- Stability testing and quality control
- Technology transfer and scale-up support from development to commercial production
Manufacturing Capabilities
- Oral Solids: Tablet and capsule manufacturing with annual capacity of 3.5 billion tablets and 680 million capsules
- Semi-Solids: 1,300 metric tons annual cGMP capacity for creams, ointments, gels, and topical products; includes emulsification, homogenization, controlled heating, viscosity management, tube filling, and jar filling
- Sustained-Release/Extended-Release: Controlled release technologies including delayed-release, sustained-release, and pulse-release formulations
- Specialized Handling: High-potent compound handling, hormone-based formulations, and DEA-licensed controlled substances (15,800 sq ft DEA-approved vault space)
Packaging & Warehousing
- Secondary packaging, labeling, and warehousing services
- Pharmaceutical serialization and aggregation
Quality & Regulatory
- cGMP-compliant manufacturing and operations
- In-process analytical testing (potency, pH, microbial limits)
- Microbiological testing lab services
Facility
The Bristol, Tennessee campus comprises:
- 475,000 sq ft commercial pharma manufacturing facility
- 250,000 sq ft warehouse
- 15,800 sq ft DEA-approved vault space
- 7-acre pharmaceutical development campus
- Full-service analytical laboratory for solids and semi-solids testing at all scales
Track Record
Over 80 products advanced from proof of concept to commercialization; established track record as a Big Pharma supplier with commercial pedigree in late-stage manufacturing support.
Locations
Headquarters & Manufacturing Facility
Bristol · Tennessee · United States
Related companies
Similar profiles by shared services, modalities, and capabilities.
Pharmaceutics International, Inc.- Formulation Development
- CMC Analytical Development
Metrics Contract Services- Formulation Development
- CMC Analytical Development
Bend Bioscience- Formulation Development
- CMC Analytical Development
CMC Pharmaceuticals, Inc.- Formulation Development
- CMC Analytical Development
Hovione- Formulation Development
- CMC Analytical Development
Quotient Sciences- Formulation Development
- CMC Analytical Development
Delpharm- Formulation Development
- Stability Testing & Storage
Cambrex- Formulation Development
- CMC Analytical Development
Submit a verified review for this organization.
Markdown mirror: /companies/upm-inc.md